|
Name of
Publication:
Drug alert class 2 no 2: immediate for action [Merck Sharp & Dohme Ltd - Tredaptive modified-release tablets]
Organisation Name:
Scottish Government Health and Social Care Directorates
Contact Name:
Irene Fazakerley
Description:
This product is being withdrawn throughout the EU after a study has shown a failure to reduce major vascular events and an increase in non-fatal serious adverse events. Both CHMP and the Pharmacovigilance Risk Assessment Committee have concluded that the benefits no longer outweigh the risks.
File size:
149 KB
|
Date of Publication:
21/01/2013
Contact Email:
irene.fazakerley@scotland.gsi.gov.uk
Contact Telephone:
0131-244 2528
|